With its COVID-19 vaccine hopeful cycling through clinical trials, shot maker Novavax is working to flesh out its executive team to help lead the company to the commercial stage. But you can’t get regulatory approval without a sturdy manufacturing operation—and now Novavax has hired an exec to get that operation in order.
Novavax tapped Ben Machielse as its executive vice president of chemistry, manufacturing and controls (CMC) as the vaccine maker works to take its COVID-19 and four-strain flu hopefuls across the finish line, the company said Monday.
Image: Novavax’s newest manufacturing head will join newly hired Chief Medical Officer Filip Dubovsky. (Novavax)
{iframe}https://www.fiercepharma.com/manufacturing/novavax-hires-new-manufacturing-to-take-covid-19-flu-vaccine-hopefuls-across-finish{/iframe}